Association of elevated α1-antichymotrypsin with cognitive impairment in a prospective study of the very old

被引:16
作者
Gabriel, SM
Marin, DB
Aisen, PS
Lantz, M
Altstiel, LD
Davis, KL
Mohs, RC
机构
[1] Brockton W Roxbury Vet Affairs Med Ctr, Dept Psychiat, Bronx, NY USA
[2] Mt Sinai Sch Med, Dept Psychiat, Bronx, NY USA
[3] Jewish Home & Hosp Aged, New York, NY USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1176/ajp.155.5.698
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The authors investigated the relationships between concentrations of two acute-phase proteins, alpha(1)-antichymotrypsin (ACT) and alpha(2)-macroglobulin (MAC), and cognitive impairment in the very old. Method: Concentrations of ACT and MAC were determined in a prospective study using sera from medically stable elderly nursing home residents. Cognitive impairment was assessed with the Mini-Mental State. Results: Concentrations of ACT were associated with greater cognitive impairment, as reflected by lower Mini-Mental State scores. This relationship did not exist for MAC. Conclusions: These data extend previous reports that patients with Alzheimer's disease have greater concentrations of ACT in their blood by demonstrating in a diagnostically diverse nursing home population a relationship between serum ACT and mental status. Elevated serum ACT in patients with compromised mental status may reflect a cerebral acute-phase response.
引用
收藏
页码:698 / 700
页数:3
相关论文
共 12 条
[1]  
AISEN PS, 1994, AM J PSYCHIAT, V151, P1105
[2]   A pilot study of prednisone in Alzheimer's disease [J].
Aisen, PS ;
Marin, D ;
Altstiel, L ;
Goodwin, C ;
Baruch, B ;
Jacobson, R ;
Ryan, T ;
Davis, KL .
DEMENTIA, 1996, 7 (04) :201-206
[3]  
AISEN PS, IN PRESS INT J GERIA
[4]   ELEVATED ALPHA(1)-ANTICHYMOTRYPSIN SERUM LEVELS IN A SUBSET OF NONDEMENTED FIRST-DEGREE RELATIVES OF ALZHEIMERS-DISEASE PATIENTS [J].
ALTSTIEL, LD ;
LAWLOR, B ;
MOHS, R ;
SCHMEIDLER, J ;
DALTON, A ;
MEHTA, P ;
DAVIS, K .
DEMENTIA, 1995, 6 (01) :17-20
[5]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[6]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[7]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[8]   SERUM ALPHA-1-ANTICHYMOTRYPSIN LEVEL AS A MARKER FOR ALZHEIMER-TYPE DEMENTIA [J].
LIEBERMAN, J ;
SCHLEISSNER, L ;
TACHIKI, KH ;
KLING, AS .
NEUROBIOLOGY OF AGING, 1995, 16 (05) :747-753
[9]   ALPHA-1-ANTICHYMOTRYPSIN AS A POSSIBLE BIOCHEMICAL MARKER FOR ALZHEIMER-TYPE DEMENTIA [J].
MATSUBARA, E ;
HIRAI, S ;
AMARI, M ;
SHOJI, M ;
YAMAGUCHI, H ;
OKAMOTO, K ;
ISHIGURO, K ;
HARIGAYA, Y ;
WAKABAYASHI, K .
ANNALS OF NEUROLOGY, 1990, 28 (04) :561-567
[10]   NEUROIMMUNE MECHANISMS IN ALZHEIMER-DISEASE PATHOGENESIS [J].
MCGEER, PL ;
ROGERS, J ;
MCGEER, EG .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1994, 8 (03) :149-158